JP2015527885A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015527885A5 JP2015527885A5 JP2015523290A JP2015523290A JP2015527885A5 JP 2015527885 A5 JP2015527885 A5 JP 2015527885A5 JP 2015523290 A JP2015523290 A JP 2015523290A JP 2015523290 A JP2015523290 A JP 2015523290A JP 2015527885 A5 JP2015527885 A5 JP 2015527885A5
- Authority
- JP
- Japan
- Prior art keywords
- immunogenic
- influenza
- pharmaceutical composition
- construct
- vaccinia virus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000002163 immunogen Effects 0.000 claims 29
- 239000008194 pharmaceutical composition Substances 0.000 claims 18
- 241000700618 Vaccinia virus Species 0.000 claims 15
- 108090000765 processed proteins & peptides Proteins 0.000 claims 12
- 206010022000 influenza Diseases 0.000 claims 11
- 108090000623 proteins and genes Proteins 0.000 claims 9
- 102000004169 proteins and genes Human genes 0.000 claims 9
- 108010076504 Protein Sorting Signals Proteins 0.000 claims 5
- 241000712461 unidentified influenza virus Species 0.000 claims 5
- 102000011931 Nucleoproteins Human genes 0.000 claims 4
- 108010061100 Nucleoproteins Proteins 0.000 claims 4
- 230000028327 secretion Effects 0.000 claims 4
- 101710154606 Hemagglutinin Proteins 0.000 claims 3
- 101710093908 Outer capsid protein VP4 Proteins 0.000 claims 3
- 101710135467 Outer capsid protein sigma-1 Proteins 0.000 claims 3
- 101710176177 Protein A56 Proteins 0.000 claims 3
- 239000012634 fragment Substances 0.000 claims 3
- 239000000185 hemagglutinin Substances 0.000 claims 3
- 230000028993 immune response Effects 0.000 claims 3
- 102000005348 Neuraminidase Human genes 0.000 claims 2
- 108010006232 Neuraminidase Proteins 0.000 claims 2
- 206010046865 Vaccinia virus infection Diseases 0.000 claims 2
- 241000700605 Viruses Species 0.000 claims 2
- 230000001939 inductive effect Effects 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- 102000004196 processed proteins & peptides Human genes 0.000 claims 2
- 230000003248 secreting effect Effects 0.000 claims 2
- 208000007089 vaccinia Diseases 0.000 claims 2
- 230000009385 viral infection Effects 0.000 claims 2
- 241000894006 Bacteria Species 0.000 claims 1
- 101150044288 C13L gene Proteins 0.000 claims 1
- 241000233866 Fungi Species 0.000 claims 1
- 108060003393 Granulin Proteins 0.000 claims 1
- 241000712431 Influenza A virus Species 0.000 claims 1
- 241000713196 Influenza B virus Species 0.000 claims 1
- 241000713297 Influenza C virus Species 0.000 claims 1
- 241000124008 Mammalia Species 0.000 claims 1
- 101100438031 Vaccinia virus (strain Western Reserve) VACWR206 gene Proteins 0.000 claims 1
- 239000000654 additive Substances 0.000 claims 1
- 230000000996 additive effect Effects 0.000 claims 1
- 239000000427 antigen Substances 0.000 claims 1
- 102000036639 antigens Human genes 0.000 claims 1
- 108091007433 antigens Proteins 0.000 claims 1
- 230000002238 attenuated effect Effects 0.000 claims 1
- 239000004566 building material Substances 0.000 claims 1
- 238000010276 construction Methods 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 244000052769 pathogen Species 0.000 claims 1
- 230000001932 seasonal effect Effects 0.000 claims 1
- 230000011664 signaling Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13/555,026 US9005632B2 (en) | 2009-11-20 | 2012-07-20 | Compositions, methods and uses for poxvirus elements in vaccine constructs against influenza virus subtypes or strains |
| US13/555,026 | 2012-07-20 | ||
| PCT/US2013/051353 WO2014015287A2 (en) | 2012-07-20 | 2013-07-19 | Compositions, methods and uses for poxvirus elements in vaccine constructs against influenza virus subtypes or strains |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2015527885A JP2015527885A (ja) | 2015-09-24 |
| JP2015527885A5 true JP2015527885A5 (OSRAM) | 2016-09-08 |
Family
ID=48948499
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015523290A Pending JP2015527885A (ja) | 2012-07-20 | 2013-07-19 | インフルエンザウイルスの亜型又は株に対するワクチン構築物におけるポックスウイルスエレメントについての組成物、方法及び使用 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US9005632B2 (OSRAM) |
| EP (1) | EP2874655A2 (OSRAM) |
| JP (1) | JP2015527885A (OSRAM) |
| AU (1) | AU2013292305A1 (OSRAM) |
| CA (1) | CA2918726A1 (OSRAM) |
| WO (1) | WO2014015287A2 (OSRAM) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9571414B2 (en) * | 2014-06-27 | 2017-02-14 | Amazon Technologies, Inc. | Multi-tiered processing using a distributed strict queue |
| WO2016046357A1 (en) * | 2014-09-26 | 2016-03-31 | Bavarian Nordic A/S | Methods and compositions for intra-nasal immunization with recombinant mva encoding flagellin |
| JP7695607B2 (ja) * | 2021-06-18 | 2025-06-19 | トヨタ紡織株式会社 | シアノバクテリアの製造方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UA68327C2 (en) | 1995-07-04 | 2004-08-16 | Gsf Forschungszentrum Fur Unwe | A recombinant mva virus, an isolated eukaryotic cell, infected with recombinant mva virus, a method for production in vitro of polypeptides with use of said cell, a method for production in vitro of virus parts (variants), vaccine containing the recombinant mva virus, a method for immunization of animals |
| RU2280075C2 (ru) | 2000-03-14 | 2006-07-20 | Бавариан Нордик А/С | Измененный штамм модифицированного вируса коровьей оспы ankara (mva) |
| CN101472941B (zh) * | 2006-03-31 | 2017-08-08 | 沃弗-威斯康星校友研究基金会 | 用于疫苗的高滴度重组流感病毒 |
| EP1925318A1 (en) | 2006-11-20 | 2008-05-28 | Paul-Ehrlich-Institut | Recombinant modified vaccinia virus Ankara (MVA)-based vaccine for the avian flu |
| EP2501405A4 (en) | 2009-11-20 | 2013-12-04 | Inviragen Inc | COMPOSITION, METHOD, AND USES OF POX VIRUS ELEMENTS IN VACCINATE CONSTRUCTS |
-
2012
- 2012-07-20 US US13/555,026 patent/US9005632B2/en not_active Expired - Fee Related
-
2013
- 2013-07-19 AU AU2013292305A patent/AU2013292305A1/en not_active Abandoned
- 2013-07-19 EP EP13745936.8A patent/EP2874655A2/en not_active Withdrawn
- 2013-07-19 CA CA2918726A patent/CA2918726A1/en not_active Abandoned
- 2013-07-19 WO PCT/US2013/051353 patent/WO2014015287A2/en not_active Ceased
- 2013-07-19 JP JP2015523290A patent/JP2015527885A/ja active Pending
-
2015
- 2015-03-09 US US14/642,480 patent/US20150246109A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016539946A5 (OSRAM) | ||
| Ma et al. | Intranasal vaccination with recombinant receptor-binding domain of MERS-CoV spike protein induces much stronger local mucosal immune responses than subcutaneous immunization: Implication for designing novel mucosal MERS vaccines | |
| Rappazzo et al. | Recombinant M2e outer membrane vesicle vaccines protect against lethal influenza A challenge in BALB/c mice | |
| IL276210B2 (en) | Mers-cov vaccine | |
| HRP20220717T1 (hr) | Modificirani pripravci mrna | |
| EP4104854A3 (en) | Multivalent vaccines for rabies virus and coronaviruses | |
| CN106659777A8 (zh) | 免疫原性组合产品 | |
| JP2016534034A5 (OSRAM) | ||
| JP2013518052A5 (OSRAM) | ||
| MX2023003875A (es) | Formulacion de una vacuna peptidica. | |
| JP2014530010A5 (OSRAM) | ||
| RU2015132962A (ru) | Иммуногенные композиции на основе вируса гриппа и их применение | |
| HRP20230359T1 (hr) | Imunogeni pripravak | |
| MX2021002586A (es) | Dosis unitaria de vacuna contra el dengue y administracion de esta. | |
| HRP20210608T1 (hr) | Postupci i pripravci za induciranje zaštitnog imuniteta protiv infekcije virusom humane imunodeficijencije | |
| FI3656395T3 (fi) | Menetelmiä ja koostumuksia suojaavan immuniteetin aikaansaamiseksi filovirusinfektiota vastaan | |
| NZ597000A (en) | Compositions and methods for administration of vaccines against dengue virus | |
| MY200841A (en) | Influenza Virus Vaccines and Uses Thereof | |
| BR112014011345A2 (pt) | partículas tipo vírus da influenza (vlps) compreendendo nicotiana tabacum produzida por hemaglutinina | |
| WO2017214596A8 (en) | Compositions and methods for preventing and treating zika virus infection | |
| PH12013501373B1 (en) | Bovine viral diarrhea virus type 1b vaccine compositions and methods | |
| EA033027B1 (ru) | Ослабленные вакцины от свиного гриппа и способы их получения и применения | |
| AR108014A1 (es) | Vacuna universal para enfermedades virales y método de vacunación | |
| AR095425A1 (es) | Vacuna, uso y procedimiento para prevenir una infección por picornavirus | |
| WO2018066999A3 (en) | Chimeric enterovirus virus-like particles |